These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6188256)

  • 21. [Treatment of refractory acute rejection after renal transplantation with lymphogloline].
    Yu LX; Bai XW; Wang JY
    Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):348-50. PubMed ID: 7842959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttransplant TLI is effective in nonhuman primates if combined with rabbit ATG.
    Carver M; Alqaisi M; Cunningham P; Gross U; Thomas F; Thomas J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):480-2. PubMed ID: 1899310
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody response and allograft outcome with deliberate donor-specific blood transfusions.
    Mendez R; Iwaki Y; Mendez RG; Bogaard T; Self B; Konoeda Y; Terasaki PI
    Transplant Proc; 1982 Jun; 14(2):378-82. PubMed ID: 7051482
    [No Abstract]   [Full Text] [Related]  

  • 24. Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin.
    Strober S; Modry DL; Hoppe RT; Pennock JL; Bieber CP; Holm BI; Jamieson SW; Stinson EB; Schroder J; Suomalainen H
    J Immunol; 1984 Feb; 132(2):1013-8. PubMed ID: 6361129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definition, diagnosis, and treatment of acute kidney rejection--the first 30 days.
    Howard RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):92-103. PubMed ID: 2421468
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged allograft survival of strong pretransplant immune responders treated with ATG.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplant Proc; 1981 Mar; 13(1 Pt 1):332-5. PubMed ID: 6455793
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of antilymphocyte induction therapy in liver transplantation: A European perspective.
    Langrehr JM; Neuhaus PJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020
    [No Abstract]   [Full Text] [Related]  

  • 28. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human T-lymphocyte receptors for sheep erythrocyte, antithymocyte (ATG), and anti-human brain globulins (AHB) in renal allograft recipients.
    Parsa I; Butt KM; Elberg AJ; Kountz SL; Satoh PS; Sutton A
    Transplant Proc; 1979 Jun; 11(2):1241-5. PubMed ID: 382498
    [No Abstract]   [Full Text] [Related]  

  • 30. New approaches to the use of antibodies for immunosuppression.
    Russell PS
    Transplant Proc; 1982 Sep; 14(3):506-8. PubMed ID: 6758236
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anti-thymocyte globulins: clinical trials during kidney transplantation].
    Murisasco A; Pollini J; Saingra S; Barnouin F; Lafon S; Mostefa-Kara S; Latour M
    Mars Med; 1972; 109(9):541-8. PubMed ID: 4565307
    [No Abstract]   [Full Text] [Related]  

  • 32. Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG?
    Geis WP; Giacchino JL; Buckingham JM; Bansal VK; Iwatsuki S; Kerman RH; Ing TS; Hano JE
    Transplant Proc; 1979 Jun; 11(2):1433-4. PubMed ID: 382533
    [No Abstract]   [Full Text] [Related]  

  • 33. Heart and kidney transplantation using total lymphoid irradiation and donor bone marrow in mongrel dogs.
    Kahn DR; Dufek JH; Hong R; Caldwell WL; Thomas FJ; Kolenda DR; Swanson DK; Struble RA
    J Thorac Cardiovasc Surg; 1980 Jul; 80(1):125-8. PubMed ID: 6991823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATG in steroid-resistant acute rejection in living related kidney transplantation: long-term evaluation.
    Bakr MA; Foda MA; Sally S; Sobh MA; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3161-2. PubMed ID: 7998103
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of antilymphocytic immunoglobulin from donkeys in kidney allotransplantation to dogs].
    Aripov UA; Arustamov DL; Karimov ShI; Popova VS; Al'bekova SN
    Eksp Khir Anesteziol; 1971; 16(2):13-7. PubMed ID: 4946088
    [No Abstract]   [Full Text] [Related]  

  • 36. [New developments in experimental urology].
    Templin R
    Z Urol Nephrol; 1979 Feb; 72(2):129-34. PubMed ID: 377847
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-dose ATGAM treatment sufficiently reduces total T-cell counts and remains clinically effective in prophylactic and anti-rejection protocols.
    Ekberg H; Källén R; Schatz H; Persson NH
    Transplant Proc; 1995 Dec; 27(6):3430-1. PubMed ID: 8540035
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship of rabbit ATG serum clearance rate to circulating T-cell level, rejection onset, and survival in cardiac transplantation.
    Bieber CP; Griepp RB; Oyer PE; David LA; Stinson EB
    Transplant Proc; 1977 Mar; 9(1):1031-6. PubMed ID: 325730
    [No Abstract]   [Full Text] [Related]  

  • 39. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine.
    Sutherland DE; Moudry-Munns KC; Gruessner A
    Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody.
    Bach JF; Dardenne M; Chatenoud L
    Transplant Proc; 1982 Sep; 14(3):509-12. PubMed ID: 6758237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.